Matt Hewitt analyst CRAIG HALLUM

Currently out of the existing stock ratings of Matt Hewitt, 174 are a BUY (85.71%), 29 are a HOLD (14.29%).

Matt Hewitt

Work Performance Price Targets & Ratings Chart

Analyst Matt Hewitt, currently employed at CRAIG HALLUM, has had 49.09% of price targets met with an average potential upside of 52.15%, reached in 361 days on average.

Matt Hewitt has documented 398 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical, Industrials sectors.

Most recent stock forecast was given on HSTM, HealthStream at 03-Nov-2026.

Wall Street Analyst Matt Hewitt

Analyst best performing recommendations are on CSBR (CHAMPIONS ONCOLOGY).
The best stock recommendation documented was for CSBR (CHAMPIONS ONCOLOGY) on 12/12/2024. The price target of $8 was fulfilled within 11 days with a profit of $2.84 (55.04%), with a performance score of 50.04.

Average potential price target upside

CDMO Avid Bioservices CDXS Codexis LGND Ligand Pharmaceuticals OMCL Omnicell RGEN Repligen SDGR Schrodinger SRGA Surgalign Holdings TDOC Teladoc TLGT Teligent VCRA Vocera Communications AKRX Akorn APEN Apollo Endosurgery APYX Apyx Medical MDXG MiMedx Group CTEK CynergisTek SLP Simulations Plus TECH Bio-Techne Corp BLFS BioLife Solutions SNCE Science 37 Holdings ANGO AngioDynamics HSTM HealthStream NEO NeoGenomics ACET Adicet Bio AP Ampco-Pittsburgh CD Chindata Group Holdings Ltd CSBR Champions Oncology HAE Haemonetics LFCR Lifecore Biomedical REPH Recro Pharma SRG Seritage Growth Properties VC Visteon Corp LCI Lannett Company ISPC iSpecimen MXCT MaxCyte CERT Certara CYRX Cryoport OABI OmniAb CLOV Clover Health Investments Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Mar-2021

$12

$12

2 years 10 days ago
(07-Nov-2024)

10/13 (76.92%)

$-0.24 (-1.96%)

27

Buy Since 09-Nov-2020

$14

$14

2 years 1 months 18 days ago
(30-Sep-2024)

5/9 (55.56%)

$2.62 (23.02%)

59

Buy Since 16-Oct-2019

$12

$12

2 years 2 months 7 days ago
(10-Sep-2024)

4/8 (50%)

$1.51 (14.39%)

91

Buy Since 16-Oct-2019

$16

$22

2 years 11 months 9 days ago
(08-Dec-2023)

2/6 (33.33%)

$11.36 (244.83%)

266

Buy

$20

$22

3 years 4 months 26 days ago
(22-Jun-2023)

1/4 (25%)

$6.26 (45.56%)

92

Show more analysts

Please expand the browser size to see the chart

Which stock is Matt Hewitt most bullish on?

Potential upside of $12.03 has been obtained for HSTM (HEALTHSTREAM)

Which stock is Matt Hewitt most reserved on?

Potential downside of $0.11 has been obtained for CYRX (CRYOPORT)

What Year was the first public recommendation made by Matt Hewitt?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?